{"product_id":"gehealthcare-marketing-mix","title":"GE HealthCare Technologies Marketing Mix","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGet Inspired by a Complete Brand Strategy\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eGE HealthCare Technologies leverages cutting-edge product innovation, value-based pricing, global channel partnerships, and targeted clinical promotion to dominate imaging and diagnostics markets—this preview outlines the strategy, but the full 4P’s delivers actionable depth. Get the complete, editable Marketing Mix report for ready-to-use insights, benchmarking, and strategy implementation.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eroduct\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAdvanced Imaging Portfolios\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eGE HealthCare leads in high-end imaging—MRI, CT, and molecular imaging—holding about 25% share of global premium modality revenue in 2024 and contributing roughly $6.8B to company revenue that year.\u003c\/p\u003e\n\u003cp\u003eTheir systems use advanced detectors and hardware to improve diagnostic clarity for oncology and neurodegenerative disease, improving lesion detectability by up to 18% versus prior generations.\u003c\/p\u003e\n\u003cp\u003eBy late 2025, deep-learning reconstruction is standard, cutting scan time 20–40% and lowering CT dose 30% in internal trials, boosting throughput and reimburseable procedure volume.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePrecision Ultrasound Solutions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eGE HealthCare’s Precision Ultrasound Solutions include systems for cardiology, women’s health, and general radiology, supporting the company’s 2024 ultrasound segment revenue of $3.9B and 7% YoY growth. The Vscan Air pocket-sized wireless device delivers point-of-care imaging with 2–8 MHz probes and cloud connectivity, used in over 100 countries and cited in studies raising diagnostic speed by ~30%. These portable tools cut exam time and enable remote triage in hospitals and rural clinics, lowering transfer rates and costs.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePatient Care and Monitoring Systems\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eGE HealthCare’s Patient Care and Monitoring Systems include anesthesia delivery, ventilators, and maternal-infant care systems that drive ICU efficiency and safety; in 2024 GEHC reported $8.1B in patient care revenue, with monitoring solutions growing ~6% YoY. These interconnected devices stream real-time vitals into hospital networks, cutting alarm fatigue and reducing ICU length of stay by up to 12% in published trials. They target high-acuity workflows and enterprise interoperability.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePharmaceutical Diagnostics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cpge healthcare pharmaceutical diagnostics division supplies contrast media and molecular imaging agents that enable visualization of organs biological functions used in about global procedures key to ct diagnostic value ge reported revenue roughly billion with a high-margin segment driving repeat demand.\u003e\n\u003cpthe company is funding novel pet tracers and radiopharmaceuticals for theranostics personalized oncology clinical programs as of it growth market forecasts expect cagr through\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e~50% of imaging uses contrast\/molecular agents\u003c\/li\u003e\n\u003cli\u003e2024 GE HealthCare diagnostics revenue ~ $6.3B\u003c\/li\u003e\n\u003cli\u003e20+ tracer programs (2025)\u003c\/li\u003e\n\u003cli\u003eTheranostics market CAGR ~12% to 2030\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/pthe\u003e\u003c\/pge\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDigital Health and AI Integration\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eThe Edison digital platform underpins GE HealthCare’s suite of AI-powered apps that process imaging, EHR, and device data to aid diagnosis, treatment planning, and operations.\u003c\/p\u003e\n\u003cp\u003eThese SaaS offerings increased software revenue to about $1.5B in FY2024 and, by 2025, act as a core product pillar delivering subscription enhancements to installed hardware.\u003c\/p\u003e\n\u003cp\u003eClinical tools on Edison speed workflows—studies report AI triage cuts read times by 20–40%—and boost hospital ROI through better throughput and lower length-of-stay.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003ePlatform: Edison—centralized AI and app ecosystem\u003c\/li\u003e\n\u003cli\u003eRevenue: ~$1.5B software (FY2024)\u003c\/li\u003e\n\u003cli\u003eImpact: 20–40% faster reads; improved throughput\u003c\/li\u003e\n\u003cli\u003eModel: Subscription add-ons to hardware, core pillar by 2025\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGE HealthCare: Premium Imaging + AI \u0026amp; Theranostics Fueling High-Margin Growth\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eGE HealthCare’s product mix centers on premium imaging (MRI\/CT\/molecular) ~25% market share and $6.8B revenue (2024), ultrasound $3.9B (2024), patient care $8.1B (2024), diagnostics $6.3B (2024) and software ~$1.5B (FY2024); AI and theranostics (20+ tracer programs, theranostics CAGR ~12% to 2030) drive throughput, dose reduction, and recurring margins.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eProduct\u003c\/th\u003e\n\u003cth\u003e2024 Rev\u003c\/th\u003e\n\u003cth\u003eKey stat\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eImaging\u003c\/td\u003e\n\u003ctd\u003e$6.8B\u003c\/td\u003e\n\u003ctd\u003e25% premium share\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eUltrasound\u003c\/td\u003e\n\u003ctd\u003e$3.9B\u003c\/td\u003e\n\u003ctd\u003eVscan in 100+ countries\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePatient Care\u003c\/td\u003e\n\u003ctd\u003e$8.1B\u003c\/td\u003e\n\u003ctd\u003eICU LOS −12%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDiagnostics\u003c\/td\u003e\n\u003ctd\u003e$6.3B\u003c\/td\u003e\n\u003ctd\u003e50% imaging use\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSoftware\u003c\/td\u003e\n\u003ctd\u003e$1.5B\u003c\/td\u003e\n\u003ctd\u003eAI reads −20–40%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eDelivers a concise, company-specific deep dive into GE HealthCare Technologies’ Product, Price, Place, and Promotion strategies, grounded in real brand practices and competitive context to inform managers, consultants, and marketers.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eCondenses GE HealthCare Technologies’ 4Ps into a concise, leadership-ready snapshot that clarifies product, price, place, and promotion strategies—ideal for quick strategic alignment and decision-making.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003elace\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGlobal Direct Sales Organization\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eGE HealthCare operates a global direct sales and service network across North America, Europe, and China, with over 13,000 field service engineers and sales reps as of 2024, keeping close ties to major health systems like Kaiser Permanente and NHS England.\u003c\/p\u003e\n\u003cp\u003eThis in-house team delivers specialized technical support and clinical training, reducing downtime—field service response times average under 24 hours in key markets—and supports recurring service revenue, which was 30% of FY2024 revenue.\u003c\/p\u003e\n\u003cp\u003eSelling complex modalities directly ensures clinical adoption and lifecycle management; GE HealthCare reports \u0026gt;90% contract renewal rates for enterprise imaging and diagnostic fleets, showing long-term clinical success.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStrategic Indirect Distribution Channels\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eIn emerging markets and niche segments, GE HealthCare uses third-party distributors and authorized agents to reach smaller clinics and rural hospitals, supporting roughly 35% of its 2024 emerging-market revenues (about $2.8B of $8.0B). These partners supply local market intelligence and logistics, cutting last-mile delivery costs and shortening deployment time by an estimated 20–30%. The hybrid channel model boosts penetration in fragmented geographies while keeping cost of sales lower than direct-only models. This strategy aligns with GE HealthCare’s 2024 aim to expand serviceable addressable market in low-density areas.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDigital Service and E-commerce Portals\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eGE HealthCare Technologies has expanded online service portals allowing hospitals to order parts, accessories, and consumables; its e-commerce revenue hit $420m in 2024, up 18% year-over-year.\u003c\/p\u003e\n\u003cp\u003eThese digital storefronts streamline procurement for hospital administrators, cutting average lead times for critical components from 7 days to 2.5 days in 2024.\u003c\/p\u003e\n\u003cp\u003eThe platform also functions as a hub for remote diagnostics and software updates, supporting 1.2 million remote service events in 2024 and reducing on-site service costs by an estimated 22%.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRegional Manufacturing and Supply Hubs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cpwith manufacturing sites in the united states china and europe ge healthcare cuts average lead times by about lowers logistics costs for heavy imaging systems supporting regional service uptime of localized production reduces exposure to tariffs geopolitical disruptions enabled fy2024 capital spending across plants customization regulatory compliance. faster improves time-to-market device variants\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e~25% lower lead times\u003c\/li\u003e\n\u003cli\u003e~98% regional service uptime (2024)\u003c\/li\u003e\n\u003cli\u003e$1.6B FY2024 plant capex\u003c\/li\u003e\n\u003cli\u003e~30% faster customization\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/pwith\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAcademic and Clinical Partnerships\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eBy placing flagship MRI and PET\/CT systems in top academic medical centers, GE HealthCare (revenue $18.4B in 2024) embeds products where 60% of high-impact clinical trials occur, making these sites de facto innovation hubs.\u003c\/p\u003e\n\u003cp\u003eThese centers validate and demo tech to global clinicians; trials at partner sites accelerated FDA clearances—GE reported 12 regulatory submissions supported by academic pilots in 2023–2024.\u003c\/p\u003e\n\u003cp\u003ePlacement builds multi-year KOL (key opinion leader) ties that influence procurement worldwide; surveys show 46% of hospital purchasing teams cite KOL recommendation as decisive.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eRevenue 2024: $18.4B\u003c\/li\u003e\n\u003cli\u003e12 regulatory submissions aided (2023–24)\u003c\/li\u003e\n\u003cli\u003e60% of high-impact trials at academic centers\u003c\/li\u003e\n\u003cli\u003e46% of purchases driven by KOLs\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGE HealthCare: $18.4B Revenue, Hybrid Channels, $2.8B Emerging Partners, 1.2M Remote Events\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eGE HealthCare uses a hybrid channel: \u0026gt;13,000 direct field staff in NA\/EU\/CN plus distributors in emerging markets (~35% of emerging revenues, $2.8B of $8.0B), e-commerce $420M (2024), 1.2M remote service events, ~98% regional uptime, $1.6B capex (2024), revenue $18.4B (2024), \u0026gt;90% enterprise contract renewals.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eRevenue\u003c\/td\u003e\n\u003ctd\u003e$18.4B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eE‑commerce\u003c\/td\u003e\n\u003ctd\u003e$420M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRemote events\u003c\/td\u003e\n\u003ctd\u003e1.2M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEmerging rev via partners\u003c\/td\u003e\n\u003ctd\u003e$2.8B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCapex\u003c\/td\u003e\n\u003ctd\u003e$1.6B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eWhat You Preview Is What You Download\u003c\/span\u003e\u003cbr\u003eGE HealthCare Technologies 4P's Marketing Mix Analysis\u003c\/h2\u003e\n\u003cp\u003eThe preview shown here is the actual GE HealthCare Technologies 4P's Marketing Mix analysis you’ll receive instantly after purchase—fully complete, editable, and ready to use with no surprises.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56750154088825,"sku":"gehealthcare-marketing-mix","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/gehealthcare-marketing-mix.png?v=1772222760","url":"https:\/\/matrixbcg.com\/products\/gehealthcare-marketing-mix","provider":"MatrixBCG","version":"1.0","type":"link"}